ImmunoBiochem's Incubator/Accelerator Round

ImmunoBiochem raised a round of funding on November 08, 2017. Investors include JLabs.

ImmunoBiochem has created a technology that enables the development of antibody drug conjugates (ADCs) targeted at intracellular tumor antigens. ADCs comprise a class of potentiated biological therape…

Articles about ImmunoBiochem's Incubator/Accelerator Round: